Tango Therapeutics TNGX Property, plant and equipment at cost
Property, plant and equipment at cost at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's property, plant and equipment at cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's property, plant and equipment at cost?
- Tango Therapeutics (TNGX) reported property, plant and equipment at cost of $17.32M in Q1 2026.
- How has Tango Therapeutics's property, plant and equipment at cost changed year-over-year?
- Tango Therapeutics's property, plant and equipment at cost increased by 4.8% year-over-year, from $16.52M to $17.32M.
- What is the long-term trend for Tango Therapeutics's property, plant and equipment at cost?
- Over 5 years (2020 to 2025), Tango Therapeutics's property, plant and equipment at cost has grown at a 25.9% compound annual growth rate (CAGR), from $5.51M to $17.41M.